Related by context. Frequent words. (Click for all words.) 73 laquinimod 72 Exenatide 72 administered subcutaneously 72 BAY #-# 70 investigational oral 70 Liraglutide 70 Alemtuzumab 69 Rivaroxaban 69 diabetic neuropathic pain 69 LY# [003] 69 oral formulation 69 integrase inhibitor 68 Asentar 68 relapsing remitting multiple sclerosis 68 Erlotinib 68 orally bioavailable 68 ELND# 68 HuMax CD# 67 investigational compound 67 Elesclomol 67 methylnaltrexone 67 transcriptase inhibitor NNRTI 67 Nexavar ® 67 Bortezomib 67 Lenalidomide 67 Sorafenib 67 SCH # 67 LY# [002] 67 immunomodulator 67 phase IIb 67 Azilect 67 PROMACTA 66 Gabapentin GR 66 Extended Release Tablets 66 ocrelizumab 66 FTY# 66 Jevtana 66 eltrombopag 66 Torisel 66 decitabine 66 Monotherapy 66 Desmoteplase 66 IMC A# 66 tocilizumab 66 daclizumab 66 Imatinib 66 Bevacizumab 66 metastatic renal cell carcinoma 66 LIALDA 65 Phase 1b trial 65 AVE# 65 vandetanib 65 6R BH4 65 Valcyte 65 temsirolimus 65 SRT# [003] 65 muraglitazar 65 biologic therapy 65 injectable formulation 65 Gemcitabine 65 Phenoptin 65 relapsed multiple myeloma 65 axitinib 65 INCB# [002] 65 Everolimus 65 Phase III Trial 65 abiraterone 65 Maraviroc 65 CoFactor 65 Pioglitazone 65 Rituximab 65 rasagiline 65 Taxotere ® 65 Phase 2a trial 65 Phase IIa clinical 64 SEROQUEL XR 64 eniluracil 64 interferon beta 1a 64 vicriviroc 64 HCV protease inhibitor 64 nitazoxanide 64 romiplostim 64 JANUVIA 64 romidepsin 64 Lialda 64 monotherapy 64 RG# [001] 64 Combination therapy 64 antiepileptic drug 64 Amigal 64 Denosumab 64 ZYBRESTAT 64 LEXIVA 64 Phase IIa trial 64 Lamivudine 64 interferon alfa 64 Tolerability 64 humanized anti 64 double blinded placebo 64 Fidaxomicin 64 Drug Candidate